Key facts
- This page summarizes Nassim Usman's Form 4 filing for GYRE THERAPEUTICS, INC. (GYRE).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Jul 2024, 18:00.
Nassim Usman - 28 Jun 2024 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)
- Reporting relationship
- Director
- Issuer ticker
- GYRE
- Reported as of
- 28 Jun 2024
- Net transaction value
- -$17,515
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2024, 18:00:33 UTC
- Prior SEC filing
- 02 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ruoyu Chen, as attorney-in-fact for Nassim Usman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nassim Usman filed Form 4 for GYRE THERAPEUTICS, INC. (GYRE) on 01 Jul 2024.
Change
- Previous filing in this sequence was filed on 02 May 2024.
- Current net transaction value: -$17,515.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GYRE
transaction
Common Stock
Options Exercise
- Transaction value
- $23,922
- Shares
- +3,452
- Change %
- +211%
- Price
- $6.93
- Shares after
- 5,088
- Date
- 28 Jun 2024
- Ownership
- Direct
GYRE
transaction
Common Stock
Sale
- Transaction value
- $41,438
- Shares
- -3,452
- Change %
- -68%
- Price
- $12.00
- Shares after
- 1,636
- Date
- 28 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
GYRE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 563
- Date
- 28 Jun 2024
- Ownership
- By The Usman Family Trust
GYRE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 77
- Date
- 28 Jun 2024
- Ownership
- By Nassim Usman IRA
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GYRE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,452
- Change %
- -1.2%
- Price
- $0.000000
- Shares after
- 278,200
- Date
- 28 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,452
- Exercise price
- $6.93
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Nassim Usman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.
Footnote F2
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.025. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F3
This option is vested in full.